MONOGRAFI
MONOGRAFI
MONOGRAFI
1. Ramipril
C23H32N2O5
Cyclopenta[b]pyrrole-2-carboxylic
416,51
acid,
1-[2-[[1-
(ethoxycarbonyl)-3-
182.17
Functional Category Diluent; plasticizer; sweetening agent; tablet and capsule diluent;
therapeutic agent; tonicity agent.
Density (bulk) 0.430 g/cm3 for powder; 0.7 g/cm3 for granules.
Density (tapped) 0.734 g/cm3 for powder; 0.8 g/cm3 for granules.
Density (true) 1.514 g/cm3
Dissociation constant pKa = 13.5 at 188C
Flash point <1508C
Flowability Powder is cohesive, granules are free flowing.
Heat of combustion 16.57 kJ/g (3.96 kcal/g)
Heat of solution _120.9 J/g (_28.9 cal/g) at 258C
Melting point 166168oC
Solubility
Solubility Practically insoluble in organic solvents, water, and acids, except hydrofluoric
acid; soluble in hot solutions of alkali hydroxide. Forms a colloidal dispersion with water.
For Aerosil, solubility in water is 150 mg/L at 25oC (pH 7).
Stability and Storage Conditions Colloidal silicon dioxide is hygroscopic but adsorbs
large quantities of water without liquefying. When used in aqueous systems at a pH
07.5, colloidal silicon dioxide is effective in increasing the viscosity of a system.
However, at a pH greater than 7.5 the viscosity increasing properties of colloidal silicon
dioxide are reduced; and at a pH greater than 10.7 this ability is lost entirely since the
silicon dioxide dissolves to form silicates.(14) Colloidal silicon dioxide powder should be
stored in a well-closed container.
Incompabilities Incompatible with diethylstilbestrol preparations.
DAFTAR PUSTAKA
The United States Pharmacopeial Convention. 2004. The United States Pharmacopeia (USP)
29th edition. Rockville(MD): The United States Pharmacopeial Convention, vol. 31(3) page 787